The stock has a 36-month beta value of 1.02. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 5 as “overweight,” 4 as “hold,” and 1 as “sell.”
The public float for XRAY is 201.14M, and at present, short sellers hold a 8.13% of that float. On November 05, 2024, the average trading volume of XRAY was 2.57M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
XRAY) stock’s latest price update
DENTSPLY Sirona Inc (NASDAQ: XRAY)’s stock price has dropped by -0.64 in relation to previous closing price of 23.49. Nevertheless, the company has seen a loss of -1.14% in its stock price over the last five trading days. accesswire.com reported 2024-11-04 that NEW YORK CITY, NY / ACCESSWIRE / November 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (NASDAQ:XRAY). Investors who purchased Dentsply Sirona securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/XRAY.
XRAY’s Market Performance
DENTSPLY Sirona Inc (XRAY) has seen a -1.14% fall in stock performance for the week, with a -7.45% decline in the past month and a -3.35% plunge in the past quarter. The volatility ratio for the week is 2.57%, and the volatility levels for the past 30 days are at 2.44% for XRAY. The simple moving average for the past 20 days is -2.98% for XRAY’s stock, with a -17.59% simple moving average for the past 200 days.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Needham repeating the rating for XRAY by listing it as a “Buy.” The predicted price for XRAY in the upcoming period, according to Needham is $29 based on the research report published on October 25, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $34. The rating they have provided for XRAY stocks is “Buy” according to the report published on August 20th, 2024.
Leerink Partners gave a rating of “Outperform” to XRAY, setting the target price at $42 in the report published on February 26th of the current year.
XRAY Trading at -6.79% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.93% of loss for the given period.
Volatility was left at 2.44%, however, over the last 30 days, the volatility rate increased by 2.57%, as shares sank -4.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.78% lower at present.
During the last 5 trading sessions, XRAY fell by -1.14%, which changed the moving average for the period of 200-days by -34.55% in comparison to the 20-day moving average, which settled at $24.06. In addition, DENTSPLY Sirona Inc saw -34.42% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 8,212 shares at the price of $24.35 back on Aug 08 ’24. After this action, LUCIER GREGORY T now owns 66,661 shares of DENTSPLY Sirona Inc, valued at $199,983 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 3,577 shares at $27.95 during a trade that took place back on May 31 ’24, which means that LUCIER GREGORY T is holding 58,374 shares at $99,976 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -5.47, with -2.54 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.69. The interest coverage ratio of the stock is -1.29.
Currently, EBITDA for the company is 638.0 million with net debt to EBITDA at 4.0. When we switch over and look at the enterprise to sales, we see a ratio of 1.71. The receivables turnover for the company is 6.59for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.33.
Conclusion
To sum up, DENTSPLY Sirona Inc (XRAY) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
